In the hope of developing more efficient stem cell-treatments for ischemic heart diseases, researchers led by Masaaki Ii (Osaka Medical College, Japan) recently assessed the outcomes of a combinatorial strategy on the ischemic myocardium. In brief, Yokoyama et al.